3
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Kinetics of (-)125Iodocyanopindolol Binding to Intact Human Mononuclear Cells

, , &
Pages 773-785 | Published online: 26 Sep 2008

References

  • Engel G., Hoyer D., Berthold R., Wagner H. (±)(125Iodo) cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 1981; 317: 277–285
  • Hoyer D., Engel G., Berthold R. Binding characteristics of (+)-, (±)- and (-)-(125(Iodo)cyanopindolol to guinea-pig left ventricle membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1982; 318: 319–329
  • Brodde O. E., Engel G., Hoyer D., Bock K. D., Weber F. The β-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (±)-125Iodocyanopindolol. Life Sci. 1981; 29: 2189–2198
  • Neve K. A., McGonigle P., Molinof P. B. Quantitative analysis of the selectivity of radioligands for subtypes of beta-adrenergic receptors. J. Pharmacol. Exp. Ther. 1986; 238: 46–53
  • Petrovic S. L., McDonald J. K., Snyder G. D., McCann S. M. Characterization of β-adrenergic receptors in rat brain and pituitary using a new high-affinity ligand, (125 I)Iodocyanopin-dolol. Brain Research 1983; 261: 249–259
  • Landmann R., Bürgisser E., Bühler F. R. Human lymphocytes as a model for beta-adrenergic receptors in clinical investigation. J. Recept. Res. 1983; 3: 71–88
  • O'Hara N., Brodde O. E. Identical binding properties of (±)- and (-)-125Iodocyanopindolol to β2-adrenoceptors in intact human lymphocytes. Arch. Int. Pharmacodyn. Ther. 1984; 272: 24–39
  • Halper J. P., Mann J. J., Weksler M. E., Bilezikian J. P., Sweeney J. A., Brown R. P., Goldbourne T. Beta-adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effect of age and gender. Life Sci. 1984; 35: 855–863
  • Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 1968; 21(Suppl. 97)77–89
  • Rodrigues de Miranda J. F., Scheres H. M.E., Salden H. J.M., Beld A. J., Klaassen A. B.M., Kuypers W. Muscarinic receptors in rat nasal mucosa are predominantly of the low affinity agonist type. Eur. J. Pharmacol. 1985; 113: 441–445
  • Graafsma S. J., Rodrigues de Miranda J. F., Thien Th. Re-dced sensitivity of lymphocyte β-adrenergic receptors in patients with endogenous depression and psychomotor agitation, letter to the editor. N. Engl. J. Med. 1986; 314: 924
  • Graafsma S. J., van Tits L. J.H., Westerhof B., van Valderen R., Lenders J. W.M., Rodrigues de Miranda J. F., Thien Th. Adrenoceptor density on human blood cells and plasma catecholamines after mental arithmetic in normotensive volunteers. J. Cardiovasc. Pharmacol. 1987; 10(suppl. 4), (in press)
  • Engel G., Hoyer D., Berthold R., Wagner H. (±)(125 Iodo)cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 1981; 317: 277–285
  • Brodde O. E. Homogeneous class of beta-1 adrenergic receptors in rat kidney: Identification by (±)-125 Iodocyanopindolol binding. Biochem. Pharmacol. 1982; 31: 1743–1747
  • Brodde O. E., Kuhlhoff F., Arroyo J., Prywarra A. No evidence for temperature-dependent changes in the pharmacological specificity of β1- and β2-adrenoceptors in rabbit lung membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1983; 322: 20–28

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.